HEADER HYDROLASE 12-MAR-14 4CT5 TITLE DDX6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DDX6; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RECA1, RECA2, RESIDUES 95-469; COMPND 5 SYNONYM: ATP-DEPENDENT RNA HELICASE P54, DEAD BOX PROTEIN 6, ONCOGENE COMPND 6 RCK; COMPND 7 EC: 3.6.4.13; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PEC_HIS_SUMO KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.OZGUR,J.BASQUIN,E.CONTI REVDAT 4 20-DEC-23 4CT5 1 REMARK REVDAT 3 18-JUN-14 4CT5 1 JRNL REVDAT 2 28-MAY-14 4CT5 1 ATOM REVDAT 1 07-MAY-14 4CT5 0 JRNL AUTH H.MATHYS,J.BASQUIN,S.OZGUR,M.CZARNOCKI-CIECIURA,F.BONNEAU, JRNL AUTH 2 A.AARTSE,A.DZIEMBOWSKI,M.NOWOTNY,E.CONTI,W.FILIPOWICZ JRNL TITL STRUCTURAL AND BIOCHEMICAL INSIGHTS TO THE ROLE OF THE JRNL TITL 2 CCR4-NOT COMPLEX AND DDX6 ATPASE IN MICRORNA REPRESSION. JRNL REF MOL.CELL V. 54 751 2014 JRNL REFN ISSN 1097-2765 JRNL PMID 24768538 JRNL DOI 10.1016/J.MOLCEL.2014.03.036 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 18661 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.5967 - 7.0482 0.96 2679 142 0.1832 0.1968 REMARK 3 2 7.0482 - 5.5966 0.97 2731 152 0.2422 0.2197 REMARK 3 3 5.5966 - 4.8899 0.99 2754 145 0.2048 0.1907 REMARK 3 4 4.8899 - 4.4431 0.98 2726 147 0.1801 0.2272 REMARK 3 5 4.4431 - 4.1248 0.98 2763 138 0.2108 0.3313 REMARK 3 6 4.1248 - 3.8817 0.98 2730 139 0.2489 0.2950 REMARK 3 7 3.8817 - 3.6873 0.99 2766 147 0.2583 0.3157 REMARK 3 8 3.6873 - 3.5269 0.97 2683 144 0.2835 0.3169 REMARK 3 9 3.5269 - 3.3911 0.96 2722 145 0.2842 0.3241 REMARK 3 10 3.3911 - 3.2741 0.97 2721 137 0.2949 0.2975 REMARK 3 11 3.2741 - 3.1718 0.98 2743 145 0.3052 0.4115 REMARK 3 12 3.1718 - 3.0811 0.97 2713 145 0.3481 0.3942 REMARK 3 13 3.0811 - 3.0000 0.98 2722 143 0.3761 0.4211 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5974 REMARK 3 ANGLE : 0.788 8079 REMARK 3 CHIRALITY : 0.033 945 REMARK 3 PLANARITY : 0.004 1037 REMARK 3 DIHEDRAL : 12.907 2229 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4CT5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1290059966. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00002 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27769 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 80.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.400 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2WAX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% (W/V) PEG 10000, 100 MM BIS-TRIS REMARK 280 PH 5.5 AND 100 MM AMMONIUM ACETATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.55800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.59150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.57200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.59150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.55800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.57200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 92 REMARK 465 SER A 93 REMARK 465 MET A 94 REMARK 465 ARG B 92 REMARK 465 SER B 93 REMARK 465 MET B 94 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 ARG A 134 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 195 CG CD CE NZ REMARK 470 LEU A 212 CG CD1 CD2 REMARK 470 ASP A 255 CG OD1 OD2 REMARK 470 LYS A 269 CG CD CE NZ REMARK 470 LEU A 282 CG CD1 CD2 REMARK 470 LYS A 294 CG CD CE NZ REMARK 470 HIS A 323 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 333 CG CD OE1 NE2 REMARK 470 LYS A 367 CG CD CE NZ REMARK 470 GLU A 371 CG CD OE1 OE2 REMARK 470 GLU A 416 CG CD OE1 OE2 REMARK 470 PHE A 444 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 456 CG CD OE1 OE2 REMARK 470 LYS A 458 CG CD CE NZ REMARK 470 MET B 109 CG SD CE REMARK 470 LYS B 118 CG CD CE NZ REMARK 470 LYS B 141 CG CD CE NZ REMARK 470 ARG B 206 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 231 CG CD CE NZ REMARK 470 ASP B 255 CG OD1 OD2 REMARK 470 LYS B 269 CG CD CE NZ REMARK 470 LYS B 294 CG CD CE NZ REMARK 470 GLU B 302 CG CD OE1 OE2 REMARK 470 GLN B 333 CG CD OE1 NE2 REMARK 470 ILE B 398 CG1 CG2 CD1 REMARK 470 LYS B 413 CG CD CE NZ REMARK 470 GLU B 416 CG CD OE1 OE2 REMARK 470 PHE B 444 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 456 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 102 85.55 59.41 REMARK 500 PRO A 281 -172.94 -69.80 REMARK 500 HIS A 291 -51.92 -125.43 REMARK 500 ASN A 335 -80.00 -82.75 REMARK 500 THR A 395 -18.10 75.15 REMARK 500 ASP A 399 37.08 -91.91 REMARK 500 CYS B 102 86.14 59.80 REMARK 500 PRO B 281 -171.91 -69.11 REMARK 500 HIS B 291 -50.25 -125.63 REMARK 500 ASN B 335 -79.32 -83.01 REMARK 500 ASP B 399 37.57 -92.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1470 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1470 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CT4 RELATED DB: PDB REMARK 900 CNOT1 MIF4G DOMAIN - DDX6 COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 3 AMINO ACIDS ARE FROM THE PROTEASE CLEAVAGE REMARK 999 SITE (RSM) DBREF 4CT5 A 95 469 UNP P26196 DDX6_HUMAN 95 469 DBREF 4CT5 B 95 469 UNP P26196 DDX6_HUMAN 95 469 SEQADV 4CT5 ARG A 92 UNP P26196 EXPRESSION TAG SEQADV 4CT5 SER A 93 UNP P26196 EXPRESSION TAG SEQADV 4CT5 MET A 94 UNP P26196 EXPRESSION TAG SEQADV 4CT5 ARG B 92 UNP P26196 EXPRESSION TAG SEQADV 4CT5 SER B 93 UNP P26196 EXPRESSION TAG SEQADV 4CT5 MET B 94 UNP P26196 EXPRESSION TAG SEQRES 1 A 378 ARG SER MET GLY ASN GLU PHE GLU ASP TYR CYS LEU LYS SEQRES 2 A 378 ARG GLU LEU LEU MET GLY ILE PHE GLU MET GLY TRP GLU SEQRES 3 A 378 LYS PRO SER PRO ILE GLN GLU GLU SER ILE PRO ILE ALA SEQRES 4 A 378 LEU SER GLY ARG ASP ILE LEU ALA ARG ALA LYS ASN GLY SEQRES 5 A 378 THR GLY LYS SER GLY ALA TYR LEU ILE PRO LEU LEU GLU SEQRES 6 A 378 ARG LEU ASP LEU LYS LYS ASP ASN ILE GLN ALA MET VAL SEQRES 7 A 378 ILE VAL PRO THR ARG GLU LEU ALA LEU GLN VAL SER GLN SEQRES 8 A 378 ILE CYS ILE GLN VAL SER LYS HIS MET GLY GLY ALA LYS SEQRES 9 A 378 VAL MET ALA THR THR GLY GLY THR ASN LEU ARG ASP ASP SEQRES 10 A 378 ILE MET ARG LEU ASP ASP THR VAL HIS VAL VAL ILE ALA SEQRES 11 A 378 THR PRO GLY ARG ILE LEU ASP LEU ILE LYS LYS GLY VAL SEQRES 12 A 378 ALA LYS VAL ASP HIS VAL GLN MET ILE VAL LEU ASP GLU SEQRES 13 A 378 ALA ASP LYS LEU LEU SER GLN ASP PHE VAL GLN ILE MET SEQRES 14 A 378 GLU ASP ILE ILE LEU THR LEU PRO LYS ASN ARG GLN ILE SEQRES 15 A 378 LEU LEU TYR SER ALA THR PHE PRO LEU SER VAL GLN LYS SEQRES 16 A 378 PHE MET ASN SER HIS LEU GLN LYS PRO TYR GLU ILE ASN SEQRES 17 A 378 LEU MET GLU GLU LEU THR LEU LYS GLY VAL THR GLN TYR SEQRES 18 A 378 TYR ALA TYR VAL THR GLU ARG GLN LYS VAL HIS CYS LEU SEQRES 19 A 378 ASN THR LEU PHE SER ARG LEU GLN ILE ASN GLN SER ILE SEQRES 20 A 378 ILE PHE CYS ASN SER SER GLN ARG VAL GLU LEU LEU ALA SEQRES 21 A 378 LYS LYS ILE SER GLN LEU GLY TYR SER CYS PHE TYR ILE SEQRES 22 A 378 HIS ALA LYS MET ARG GLN GLU HIS ARG ASN ARG VAL PHE SEQRES 23 A 378 HIS ASP PHE ARG ASN GLY LEU CYS ARG ASN LEU VAL CYS SEQRES 24 A 378 THR ASP LEU PHE THR ARG GLY ILE ASP ILE GLN ALA VAL SEQRES 25 A 378 ASN VAL VAL ILE ASN PHE ASP PHE PRO LYS LEU ALA GLU SEQRES 26 A 378 THR TYR LEU HIS ARG ILE GLY ARG SER GLY ARG PHE GLY SEQRES 27 A 378 HIS LEU GLY LEU ALA ILE ASN LEU ILE THR TYR ASP ASP SEQRES 28 A 378 ARG PHE ASN LEU LYS SER ILE GLU GLU GLN LEU GLY THR SEQRES 29 A 378 GLU ILE LYS PRO ILE PRO SER ASN ILE ASP LYS SER LEU SEQRES 30 A 378 TYR SEQRES 1 B 378 ARG SER MET GLY ASN GLU PHE GLU ASP TYR CYS LEU LYS SEQRES 2 B 378 ARG GLU LEU LEU MET GLY ILE PHE GLU MET GLY TRP GLU SEQRES 3 B 378 LYS PRO SER PRO ILE GLN GLU GLU SER ILE PRO ILE ALA SEQRES 4 B 378 LEU SER GLY ARG ASP ILE LEU ALA ARG ALA LYS ASN GLY SEQRES 5 B 378 THR GLY LYS SER GLY ALA TYR LEU ILE PRO LEU LEU GLU SEQRES 6 B 378 ARG LEU ASP LEU LYS LYS ASP ASN ILE GLN ALA MET VAL SEQRES 7 B 378 ILE VAL PRO THR ARG GLU LEU ALA LEU GLN VAL SER GLN SEQRES 8 B 378 ILE CYS ILE GLN VAL SER LYS HIS MET GLY GLY ALA LYS SEQRES 9 B 378 VAL MET ALA THR THR GLY GLY THR ASN LEU ARG ASP ASP SEQRES 10 B 378 ILE MET ARG LEU ASP ASP THR VAL HIS VAL VAL ILE ALA SEQRES 11 B 378 THR PRO GLY ARG ILE LEU ASP LEU ILE LYS LYS GLY VAL SEQRES 12 B 378 ALA LYS VAL ASP HIS VAL GLN MET ILE VAL LEU ASP GLU SEQRES 13 B 378 ALA ASP LYS LEU LEU SER GLN ASP PHE VAL GLN ILE MET SEQRES 14 B 378 GLU ASP ILE ILE LEU THR LEU PRO LYS ASN ARG GLN ILE SEQRES 15 B 378 LEU LEU TYR SER ALA THR PHE PRO LEU SER VAL GLN LYS SEQRES 16 B 378 PHE MET ASN SER HIS LEU GLN LYS PRO TYR GLU ILE ASN SEQRES 17 B 378 LEU MET GLU GLU LEU THR LEU LYS GLY VAL THR GLN TYR SEQRES 18 B 378 TYR ALA TYR VAL THR GLU ARG GLN LYS VAL HIS CYS LEU SEQRES 19 B 378 ASN THR LEU PHE SER ARG LEU GLN ILE ASN GLN SER ILE SEQRES 20 B 378 ILE PHE CYS ASN SER SER GLN ARG VAL GLU LEU LEU ALA SEQRES 21 B 378 LYS LYS ILE SER GLN LEU GLY TYR SER CYS PHE TYR ILE SEQRES 22 B 378 HIS ALA LYS MET ARG GLN GLU HIS ARG ASN ARG VAL PHE SEQRES 23 B 378 HIS ASP PHE ARG ASN GLY LEU CYS ARG ASN LEU VAL CYS SEQRES 24 B 378 THR ASP LEU PHE THR ARG GLY ILE ASP ILE GLN ALA VAL SEQRES 25 B 378 ASN VAL VAL ILE ASN PHE ASP PHE PRO LYS LEU ALA GLU SEQRES 26 B 378 THR TYR LEU HIS ARG ILE GLY ARG SER GLY ARG PHE GLY SEQRES 27 B 378 HIS LEU GLY LEU ALA ILE ASN LEU ILE THR TYR ASP ASP SEQRES 28 B 378 ARG PHE ASN LEU LYS SER ILE GLU GLU GLN LEU GLY THR SEQRES 29 B 378 GLU ILE LYS PRO ILE PRO SER ASN ILE ASP LYS SER LEU SEQRES 30 B 378 TYR HET ACT A1470 7 HET ACT B1470 7 HETNAM ACT ACETATE ION FORMUL 3 ACT 2(C2 H3 O2 1-) HELIX 1 1 GLU A 97 CYS A 102 5 6 HELIX 2 2 LYS A 104 GLU A 113 1 10 HELIX 3 3 SER A 120 LEU A 131 1 12 HELIX 4 4 LYS A 146 LEU A 158 1 13 HELIX 5 5 THR A 173 SER A 188 1 16 HELIX 6 6 ASN A 204 LEU A 212 1 9 HELIX 7 7 THR A 222 GLY A 233 1 12 HELIX 8 8 GLU A 247 LEU A 252 1 6 HELIX 9 9 PHE A 256 THR A 266 1 11 HELIX 10 10 PRO A 281 HIS A 291 1 11 HELIX 11 11 THR A 317 LEU A 332 1 16 HELIX 12 12 SER A 343 SER A 355 1 13 HELIX 13 13 ARG A 369 ASN A 382 1 14 HELIX 14 14 LEU A 414 GLY A 423 1 10 HELIX 15 15 THR A 439 ASP A 441 5 3 HELIX 16 16 ASP A 442 LEU A 453 1 12 HELIX 17 17 ASP A 465 TYR A 469 5 5 HELIX 18 18 GLU B 97 CYS B 102 5 6 HELIX 19 19 LYS B 104 MET B 114 1 11 HELIX 20 20 SER B 120 LEU B 131 1 12 HELIX 21 21 LYS B 146 LEU B 158 1 13 HELIX 22 22 THR B 173 SER B 188 1 16 HELIX 23 23 ASN B 204 LEU B 212 1 9 HELIX 24 24 THR B 222 GLY B 233 1 12 HELIX 25 25 GLU B 247 LEU B 252 1 6 HELIX 26 26 PHE B 256 THR B 266 1 11 HELIX 27 27 PRO B 281 LEU B 292 1 12 HELIX 28 28 THR B 317 LEU B 332 1 16 HELIX 29 29 SER B 343 SER B 355 1 13 HELIX 30 30 ARG B 369 ASN B 382 1 14 HELIX 31 31 LEU B 414 GLY B 423 1 10 HELIX 32 32 ASP B 442 LEU B 453 1 12 HELIX 33 33 ASP B 465 TYR B 469 5 5 SHEET 1 AA 7 VAL A 196 THR A 199 0 SHEET 2 AA 7 VAL A 218 ALA A 221 1 O VAL A 218 N MET A 197 SHEET 3 AA 7 ALA A 167 ILE A 170 1 O ALA A 167 N VAL A 219 SHEET 4 AA 7 MET A 242 ASP A 246 1 O MET A 242 N MET A 168 SHEET 5 AA 7 GLN A 272 SER A 277 1 O GLN A 272 N ILE A 243 SHEET 6 AA 7 ILE A 136 ARG A 139 1 O ILE A 136 N LEU A 275 SHEET 7 AA 7 TYR A 296 ILE A 298 1 O TYR A 296 N LEU A 137 SHEET 1 AB 7 CYS A 361 TYR A 363 0 SHEET 2 AB 7 ASN A 387 CYS A 390 1 O ASN A 387 N PHE A 362 SHEET 3 AB 7 GLN A 336 PHE A 340 1 O SER A 337 N LEU A 388 SHEET 4 AB 7 VAL A 403 ASN A 408 1 N ASN A 404 O GLN A 336 SHEET 5 AB 7 LEU A 433 ILE A 438 1 O LEU A 433 N VAL A 406 SHEET 6 AB 7 THR A 310 TYR A 315 1 O THR A 310 N ALA A 434 SHEET 7 AB 7 LYS A 458 PRO A 459 1 O LYS A 458 N TYR A 313 SHEET 1 BA 7 VAL B 196 THR B 199 0 SHEET 2 BA 7 VAL B 218 ALA B 221 1 O VAL B 218 N MET B 197 SHEET 3 BA 7 ALA B 167 ILE B 170 1 O ALA B 167 N VAL B 219 SHEET 4 BA 7 MET B 242 ASP B 246 1 O MET B 242 N MET B 168 SHEET 5 BA 7 GLN B 272 SER B 277 1 O GLN B 272 N ILE B 243 SHEET 6 BA 7 ILE B 136 ARG B 139 1 O ILE B 136 N LEU B 275 SHEET 7 BA 7 TYR B 296 ILE B 298 1 O TYR B 296 N LEU B 137 SHEET 1 BB 7 CYS B 361 TYR B 363 0 SHEET 2 BB 7 ASN B 387 CYS B 390 1 O ASN B 387 N PHE B 362 SHEET 3 BB 7 GLN B 336 PHE B 340 1 O SER B 337 N LEU B 388 SHEET 4 BB 7 VAL B 403 ASN B 408 1 N ASN B 404 O GLN B 336 SHEET 5 BB 7 LEU B 433 ILE B 438 1 O LEU B 433 N VAL B 406 SHEET 6 BB 7 THR B 310 TYR B 315 1 O THR B 310 N ALA B 434 SHEET 7 BB 7 LYS B 458 PRO B 459 1 O LYS B 458 N TYR B 313 CISPEP 1 THR A 144 GLY A 145 0 -5.19 CISPEP 2 THR B 144 GLY B 145 0 -5.58 SITE 1 AC1 4 CYS A 102 ARG B 373 PHE B 377 PHE B 394 SITE 1 AC2 3 ASN A 374 PHE A 377 CYS B 102 CRYST1 113.116 113.144 77.183 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008840 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008838 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012956 0.00000